CoChat

Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell–Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4

Open access
Volonté, Andrea, Di Tomaso, Tiziano, Spinelli, Michela, Todaro, Matilde, Sanvito, Francesca, Albarello, Luca, Bissolati, Massimiliano, Ghirardelli, Luca, Orsenigo, Elena, Ferrone, Soldano, Doglioni, Claudio, Stassi, Giorgio, Dellabona, Paolo, Staudacher, Carlo, Parmiani, Giorgio, Maccalli, Cristina · 2014 · The Journal of Immunology
Cited by 118

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Cancer-initiating cells (CICs) that are responsible for tumor initiation, propagation, and resistance to standard therapies have been isolated from human solid tumors, including colorectal cancer (CRC). The aim of this study was to obtain an immunological profile of CRC-derived CICs and to identify CIC-associated target molecules for T cell immunotherapy. We have isolated cells with CIC properties along with their putative non-CIC autologous counterparts from human primary CRC tissues. These CICs have been shown to display “tumor-initiating/stemness” properties, including the expression of CIC-associated markers (e.g., CD44, CD24, ALDH-1, EpCAM, Lgr5), multipotency, and tumorigenicity following injection in immunodeficient mice. The immune profile of these cells was assessed by phenotype analysis and by in vitro stimulation of PBMCs with CICs as a source of Ags. CICs, compared with non-CIC counterparts, showed weak immunogenicity. This feature correlated with the expression of high levels of immunomodulatory molecules, such as IL-4, and with CIC-mediated inhibitory activity for anti-tumor T cell responses. CIC-associated IL-4 was found to be responsible for this negative function, which requires cell-to-cell contact with T lymphocytes and which is impaired by blocking IL-4 signaling. In addition, the CRC-associated Ag COA-1 was found to be expressed by CICs and to represent, in an autologous setting, a target molecule for anti-tumor T cells. Our study provides relevant information that may contribute to designing new immunotherapy protocols to target CICs in CRC patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.1301342

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 118

Metadata

Authors
Volonté, A., Di Tomaso, T., Spinelli, M., Todaro, M., Sanvito, F., Albarello, L., Bissolati, M., Ghirardelli, L., Orsenigo, E., Ferrone, S., Doglioni, C., Stassi, G., Dellabona, P., Staudacher, C., Parmiani, G., & Maccalli, C.
Venue
The Journal of Immunology
Published
2014-01-01
Volume
192
Issue
1
Pages
523-532
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W1900663669
Cited by
118
References
1
FWCI
4.11
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell–Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4. https://app.cochat.ai/papers/10.4049/jimmunol.1301342
The paper
Volonté, A., Di Tomaso, T., Spinelli, M., Todaro, M., Sanvito, F., Albarello, L., Bissolati, M., Ghirardelli, L., Orsenigo, E., Ferrone, S., Doglioni, C., Stassi, G., Dellabona, P., Staudacher, C., Parmiani, G., & Maccalli, C. (2014). Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell–Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4. The Journal of Immunology. https://doi.org/10.4049/jimmunol.1301342

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.